Government ContextGovernment Context
TopicsAgenciesOrganizationsDocumentsPricingLog inCreate account
TopicsAgenciesOrganizationsDocumentsPricing
LoginCreate account
Organizations › Matt Mahoney
MM

Matt Mahoney

Advocacy/org/matt-mahoney
Comments
6
Dockets
1
Support
6
Oppose
0

Activity

No recent organization activity yet. Historical comments remain available in the record.

Comment record

Recent public comments attributed to this organization.

  • General Considerations for the Use of New Approach Methodologies in Drug Development; Guidance for Industry - Draft Guidance
    May 20Support
  • General Considerations for the Use of New Approach Methodologies in Drug Development; Guidance for Industry - Draft Guidance
    May 20Support
  • General Considerations for the Use of New Approach Methodologies in Drug Development; Guidance for Industry - Draft Guidance
    May 20Support
  • General Considerations for the Use of New Approach Methodologies in Drug Development; Guidance for Industry - Draft Guidance
    May 20Support
  • General Considerations for the Use of New Approach Methodologies in Drug Development; Guidance for Industry - Draft Guidance
    May 20Support
  • General Considerations for the Use of New Approach Methodologies in Drug Development; Guidance for Industry - Draft Guidance
    May 20Support
Government ContextGovernment Context

Track federal rulemaking documents, topics, and agencies — built on primary sources across the federal government.

ExploreDocumentsTopicsAgenciesOrganizations
CompanyAboutData sourcesPricing
LegalPrivacyTerms
© 2026 Government Context. Built on primary government sources.Not affiliated with any U.S. government agency.